Assessment of ovarian cancer tumors treated with intraperitoneal cisplatin therapy by nanoscopic X-ray fluorescence imaging

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Laforce, Brecht ^a   Carlier, Charlotte ^b   Vekemans, Bart ^a   Villanova, Julie ^c   Tucoulou, Rémi ^c   Ceelen, Wim ^b   Vincze, Laszlo ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PLATINUM;

ANIMAL; COMPUTER SIMULATION; DATA MINING; DIAGNOSTIC IMAGING; FEMALE; FLUORESCENCE; INTRAPERITONEAL DRUG ADMINISTRATION; MONTE CARLO METHOD; NANOTECHNOLOGY; NUDE MOUSE; OVARY TUMOR; PATHOLOGY; PROCEDURES; TUMOR CELL LINE; X RAY;

ANIMALS; CELL LINE, TUMOR; CISPLATIN; COMPUTER SIMULATION; DATA MINING; DIAGNOSTIC IMAGING; FEMALE; FLUORESCENCE; INJECTIONS, INTRAPERITONEAL; MICE, NUDE; MONTE CARLO METHOD; NANOTECHNOLOGY; OVARIAN NEOPLASMS; PLATINUM; X-RAYS;

EID: 84979266842     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29999     Document Type: Article

References (33)

1. Ferlay, J., Shin, H.-R., Bray, F., Forman, D., Mathers, C. & Parkin, D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127, 2893-2917 (2010).
2. Bast, R. C., Hennessy, B. & Mills, G. B. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9, 415-428 (2009).
3. Zivanovic, O. et al. HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer. International journal of cancer Journal international du cancer 136, 699-708 (2015).
4. Bijelic, L., Sugarbaker, P. H. & Stuart, O. A. Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients. Gastroenterology Research and Practice 2012, 5 (2012).
5. van der Vange, N. et al. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 26, 663-668 (2000).
6. Grosso, G., Rossetti, D., Coccolini, F., Bogani, G., Ansaloni, L. & Frigerio, L. Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: a survey. Archives of gynecology and obstetrics 290, 425-434 (2014).
7. Tannock, I. F., Lee, C. M., Tunggal, J. K., Cowan, D. S. & Egorin, M. J. Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clinical cancer research: an official journal of the American Association for Cancer Research 8, 878-884 (2002).
8. Siddik, Z. H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279 (2003).
9. Flessner, M. F., Choi, J., Credit, K., Deverkadra, R. & Henderson, K. Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors. Clinical cancer research: an official journal of the American Association for Cancer Research 11, 3117-3125 (2005).
10. Tredan, O., Galmarini, C. M., Patel, K. & Tannock, I. F. Drug resistance and the solid tumor microenvironment. Journal of the National Cancer Institute 99, 1441-1454 (2007).
11. Sun, Y. et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nature medicine 18, 1359-1368 (2012).
12. Kartalou, M. & Essigmann, J. M. Mechanisms of resistance to cisplatin. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 478, 23-43 (2001).
13. Davis, K. J., Carrall, J. A., Lai, B., Aldrich-Wright, J. R., Ralph, S. F. & Dillon, C. T. Does cytotoxicity of metallointercalators correlate with cellular uptake or DNA affinity? Dalton transactions (Cambridge, England: 2003) 41, 9417-9426 (2012).
14. Gil, S., Carmona, A., Martinez-Criado, G., Leon, A., Prezado, Y. & Sabes, M. Analysis of platinum and trace metals in treated glioma rat cells by X-ray fluorescence emission. Biological trace element research 163, 177-183 (2015).
15. Zhang, J. Z. et al. Getting to the core of platinum drug bio-distributions: the penetration of anti-cancer platinum complexes into spheroid tumour models. Metallomics: integrated biometal science 4, 1209-1217 (2012).
16. Ortega, R., Moretto, P., Fajac, A., Benard, J., Llabador, Y. & Simonoff, M. Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells. Cellular and molecular biology (Noisy-le-Grand, France) 42, 77-88 (1996).
17. Ilinski, P. et al. The direct mapping of the uptake of platinum anticancer agents in individual human ovarian adenocarcinoma cells using a hard X-ray microprobe. Cancer research 63, 1776-1779 (2003).
18. De Samber, B. et al. Dual detection X-ray fluorescence cryotomography and mapping on the model organism Daphnia magna. Powder Diffraction 25, 169-174 (2010).
19. Silversmit, G. et al. X-ray Fluorescence Nanotomography on Cometary Matter from Comet 81P/Wild2 Returned by Stardust. Analytical Chemistry 81, 6107-6112 (2009).
20. Schmitz, S. et al. In situ identification of a CAI candidate in 81P/Wild 2 cometary dust by confocal high resolution synchrotron X-ray fluorescence. Geochimica Et Cosmochimica Acta 73, 5483-5492 (2009).
21. Laforce, B. et al. Nanoscopic X-ray Fluorescence Imaging of Meteoritic Particles and Diamond Inclusions. Analytical Chemistry 86, 12369-12374 (2014).
22. Casadio, F. & Rose, V. High-resolution fluorescence mapping of impurities in historical zinc oxide pigments: hard X-ray nanoprobe applications to the paints of Pablo Picasso. Applied Physics a-Materials Science & Processing 111, 1-8 (2013).
23. Martinez-Criado, G. et al. ID16B: a hard X-ray nanoprobe beamline at the ESRF for nano-analysis. Journal of Synchrotron Radiation 23, 344-352 (2016).
24. Florea, A.-M. & Busselberg, D. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects. Cancers 3, 1351 (2011).
25. Wu, X. D. et al. Top 10 algorithms in data mining. Knowledge and Information Systems 14, 1-37 (2008).
26. Vekemans, B., Janssens, K., Vincze, L., Aerts, A., Adams, F. & Hertogen, J. Automated segmentation of μ-XRF image sets. X-Ray Spectrometry 26, 333-346 (1997).
27. Hughes, C. S., Postovit, L. M. & Lajoie, G. A. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10, 1886-1890 (2010).
28. Schoonjans, T., SolE, V. A., Vincze, L., Sanchez del Rio, M., Appel, K. & Ferrero, C. A general Monte Carlo simulation of energydispersive X-ray fluorescence spectrometers- Part 6. Quantification through iterative simulations. Spectrochimica Acta Part B: Atomic Spectroscopy 82, 36-41 (2013).
29. Vekemans, B., Janssens, K., Vincze, L., Adams, F. & Vanespen, P. Analysis, of x-ray-spectra, by iterative least-squares (axil)- new developments. X-Ray Spectrometry 23, 278-285 (1994).
30. Vekemans, B., Janssens, K., Vincze, L., Adams, F. & Vanespen, P. Comparison, of several background compensation methods useful for evaluation of energy-dispersive x-ray-fluorescence spectra. Spectrochimica Acta Part B-Atomic Spectroscopy 50, 149-169 (1995).
31. Schoonjans, T. et al. A general Monte Carlo simulation of energy dispersive X-ray fluorescence spectrometers- Part 5: Polarized radiation, stratified samples, cascade effects, M-lines. Spectrochimica Acta Part B: Atomic Spectroscopy 70, 10-23 (2012).
32. Vincze, L., Janssens, K., Adams, F., Rivers, M. L. & Jones, K. W. A general Monte Carlo simulation of ED-XRF spectrometers. II: Polarized monochromatic radiation, homogeneous samples. Spectrochimica Acta Part B: Atomic Spectroscopy 50, 127-147 (1995).
33. Vincze, L., Janssen, K. & Adams, F. A general Monte Carlo simulation of energy-dispersive X-ray fluorescence spectrometers-I. Spectrochimica Acta Part B: Atomic Spectroscopy 48, 55-573 (1993).